#womens-health
Global Menopause Treatment Market to Surpass USD 31.95 Billion by 2035 Amid Rising Demand for Personalized and Non-Hormonal Therapies – SNS Insider
U.S. market projected to hit USD 8.82 Billion by 2035, while Europe market is expected to reach USD 8.92 Billion driven by expanding women’s health initiatives and HRT adoption. U.S. market projected to hit USD 8.82 Billion by 2035, while Europe market is exp…
Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages say
Sun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in women's health. The deal diversifies Sun Pharma's portfolio into women's health and biosimilars, with analysts from Mor…
Sun's strong gravity helps India Inc's pull
Sun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies Sun Pharma's portfolio in critical areas like dermatology, oncology, and women’s health, while providing a gateway to new…